Search

everythinglearnresearchcommunity

for

Search:↓

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Targeted cancer therapies often cause serious skin problems that need careful management.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Bezafibrate treatment improved skin and spleen health in aging mice but didn't extend lifespan.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Tofacitinib may help treat hair loss in children with alopecia areata.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.